Introduction
In the UK, an ambitious public reporting (PR) programme has been implemented in the last few years, steered by various high profile scandals about quality care outcomes [1, 2] . In December 2012, NHS England published its 2013/14 planning guidance specifying -amongst other -the aim to improve patient care through better commissioning of services, and to support patients in making informed choices, implemented via public reporting of (initially) ten specialities (better known as 'Offer 2') [3] . Today, PR is seen as a central tool for quality improvement and since 2013 individual surgeons' outcomes are made public via the patient portal 'NHS choices' [4] . Data has been published for more than 5000 consultant surgeons in 12 specialties (Adult cardiac surgery, Bariatric surgery, Colorectal surgery, Endocrine and thyroid surgery, Head and neck cancer surgery, Interventional cardiology, Lung cancer, Neurosurgery, Orthopedic surgery and Upper gastro-intestinal surgery). Data sources and outcome measures vary among specialties, but all include mortality rates (MR) of patients.
The idea to publicly report provider outcomes in order to ensure and improve quality is not new. Nearly 30 years ago, the Healthcare Financing Authority (HCFA) published annual mortality rates of Medicare patients in hospitals in the USA in 1987. Shortly after that, in 1989, the most studied PR scheme, the New York Cardiac Surgery Reporting System (CSRS) was initiated. In New York State, hospitals needed to obtain a certificate in order to offer cardiac surgery, and mandatory PR outcomes have been enforced since 1991. From 1989 to 1992 mortality rates dropped from 3.5% to 2.8% (41% decrease of risk-adjusted in-hospital mortality) [5] , while nationally it only decreased 18% between 1987 to 1990 (30-day MR). In the 1990s, Pennsylvania and Massachusetts also started surgery-focused PR.
Today, PR is a widespread tool to measure and advertise the quality of nursing homes, hospitals and healthcare-maintenance-organisations (HMOs) [6] . While in the English NHS surgeon outcomes were available before, they were not specifically released to the patients (but reported embedded on hospital web sites), not systematically reported in a common, standardized platform and not covering the wide range of specialities involved now. Thus, the recent publication of surgeon outcomes has generated substantial debate in academia and policy since its publication on NHS Choices in 2013/2014.
The assumption is that public reporting unfolds its effects via a range of pathways [7, 8] . Generally, a distinction is made between pathways referring to the principle-agent-relationship where patients are empowered by public reporting to make better choices, or pathways related to competition theory, whereas providers would improve outcomes to compete for patients. In practice, there are alternative mechanisms through which public reporting could affect outcomes. Werner [8] outlines 4 possible mechanisms: 1. patients might choose high-quality providers; 2.
GPs might refer to high-quality providers; 3. Purchasers select high-quality providers; 4. Providers themselves react in response to PR. In terms of patient choice, a growing body of evidence shows that PR of outcomes only have a limited impact: Patients have difficulties understanding comparative PR data, especially if different measures are contradicting [9, 10] . Other studies have found that consumers might value own experience or recommendation from family and friends more than comparative outcomes information [11] . In one study, fewer than 10% of patients looked at performance data [12] ; in another, only 12% of patients who had undergone Coronary Artery Bypass Graft (CABG) surgery in NY knew about PR and fewer than 1% were able to state the performance of their surgeon correctly [13] . In terms of GPs referral to high quality providers, the proposition is that they would act as agents for their clients, but in fact evidence suggests that GPs also value informal sources of quality information more than performance ratings [14] . There is insufficient evidence on purchasing models for surgeon outcomes, even though this is an area of increasing importance as many health systems start to focus on purchasing for value rather than services. Research suggests that a large part of the impact of PR is amongst providers themselves [15] [16] [17] [18] [19] .
There is a growing body of evidence about what the impacts of PR might be. Yet, a large volume of previous research on public disclosure focused at the hospital level, rather than individual surgeon level, and didn't sufficiently focus on the question by way of which mechanisms PR influences quality and which health system structures, governance arrangements and, broadly, prerequisites need to be in place for public reporting to be effective. However, this very question is a key to understanding the potential effects of public reporting and assessing whether research evidence stemming from one health system can be applied to another (here: the NHS in the UK).
The aims of this review are therefore to assess the evidence on whether and how public reporting of outcomes can be an incentive for surgeons to improve quality. Furthermore, we investigate whether the literature contains evidence regarding two key tenets of the UK surgeonlevel outcomes public reporting initiative: (i) surgeons discussing their outcomes with patients, GPs, CCGs or managers in order to improve the quality of care (as indicated in the NHS planning document "Offer 2"), or (ii) public reporting leading to adverse patient selection, as feared by the surgical specialties [20] . We then (iii) discuss the findings and consider the potential impact of the current UK surgeon level reporting initiative and (iv) propose some key lessons and contextual factors that should be considered by other countries that are in the process of devising a surgeon level public disclosure strategy.
Methods
We gathered and assessed the literature on public reporting of surgeon outcomes, and synthesised the effects and mechanisms from this literature. Methods used to collect and analyse the information contributing to this review followed the PICO framework [21] , PRISMA statement [22] and Hawker et al [23] tool for quality assessment of the retrieved papers.
Search strategy
Translating the question into search terms was informed by the PICO framework that has been recommended for literature review about clinical questions [21] . The framework includes the patient target group (P) , intervention (I), comparison group (C) and outcome (O). For the purpose of this review, a comparison group was not included into the search terms.
Target population were individual surgeons or surgery departments. To extend the number of potential hits, all known US states with a PR system or known USA-wide PR systems were included, as they might be mentioned in the title rather than "surgeon". This approach was informed by the review by Totten et. al on a related topic [24] . In this way, all present literature, also from outside the USA, could be included.
As PR was the intervention, all synonyms for PR or outcomes were included in the search. As outcomes, all terms referring to consequences and assessment were included (see Appendix A).
Starting from these initial search terms, related Emtree and MESH terms were compiled and linked using Bolean operators: search terms were linked with OR and concepts with AND. The search was conducted on 15.07.2015 (Appendix B). The search was conducted in Medline, EconLit and Embase. The search was limited to all studies published after 1980, as the first PR initiative started in 1989. Further limits were human and English language. Due to the number of results, the search was further limited in Medline and Embase to title and abstracts. For the search in EconLit, only 3 concepts were applied and no limits, due to the much smaller number of results than in Medline and Embase.
Study selection
The initial results were screened according to their title and potential relevance to PR. In a second step the abstracts were considered. Of the remaining studies, the full text was retrieved if possible and pre-defined inclusion and exclusion criteria applied (Table 1) . To make sure all relevant studies would be included, even if not found in the systematic search, reference lists of included studies were perused to find further relevant studies (snowballing). For the purpose of this review, only primary studies were considered. Literature reviews were excluded, but the reference lists of systematic reviews were used to further check that no relevant study was left out. To ensure the quality of the review, only peer-reviewed articles were included. 
Quality assessment
Cochrane Effective Practice and Organisation of Care Group (EPOC) provides detailed guidelines on how to assess the quality of studies, mostly clinical trials [25] . Due to the diverse nature of the studies included, the tool was found unfit to assess the quality of qualitative studies.
To do justice to the different types of studies, a checklist developed by Hawker et al [23, 26] was used, which can be applied to studies with qualitative and quantitative methods. It has 9 categories (abstract, introduction, methods, sampling, results, bias, analysis, transferability and implications) that can be rated with 1 to 4 points in their quality and added up to a cumulative score between 9 and 36. The results can be seen in Appendix C.
Data extraction
Again in accordance with Cochrane recommendations, the Cochrane data extraction worksheet [25] was adapted to fit the question and scope of this review. A meta-analysis of the study data was not attempted due to the various study designs and backgrounds.
Results

Studies found and evaluated
The database search led to initially 710 publications being found, of which 663 remained after exclusion of duplicates. After screening titles, 112 studies were identified as potentially relevant, of which 50 were chosen for full text reading after reviewing abstracts. 10 of these were included in the review. The screening of the reference list resulted into another 10 studies being located. Thus, in total, 25 studies were included into the review. 
Key themes in the literature
The most frequent issue of PR addressed in the literature is the potential detrimental effect of PR on access to surgery -the assumption that surgeons might reject high risk patients because of the fear of becoming an outlier in the mortality statistics. All other themes were addressed far less commonly, particularly those related to the assumptions of "Offer 2", namely that patients use the information to choose a surgeon or that GPs and purchasers use the reports to contract surgeons. Likewise, we didn´t find studies that describe the consequences of patients confronting the hospital/surgeon and requesting, because of their outcomes, a reassignment. Table 2 provides an overview on the studies included and on the outcomes of interest (Table 2 ). Adverse patient selection was the most frequently studied outcome of public reports. Of the studies included in this review, 5 reported a positive or no effect on access to surgery, one a transient effect. The majority of the studies (n=14) however reported a negative effect on patient selection, suggesting that surgeons were less likely to accept high risk patients after the introduction of public reporting. Table 3 summarizes the result of the studies on adverse selection as a consequence of public reporting of surgeon outcomes (Table 3) .
Adverse selection as a potential consequence of public reporting
Of the studies addressing adverse selection, quality and strength of evidence varied considerably: For example, Hannan et al [27] reported a minor effect of PR, with 40% of NY cardiologists influenced by PR, but only 6% claiming to be strongly influenced. Narins et al [28] and Schneider et al [29] both reported a majority of cardiac surgeons being less likely to accept a high risk patient. Hannan et al [30] and Glance et al [31] found in a sample of 31 hospitals and 87 surgeons that high risk patients were less likely operated on by surgeons with high performance. This is consistent with the findings of Dranove et al [32] , we found that the relative illness severity among AMI patients in NY and Pennsylvania declined, Moscucci et al [33] who detected a decline in the rates of comorbidities in AMI patients, while Omoigui found that patients referred from NY to Ohio were sicker than other referrals or patients from Ohio itself. Glance et al Hannan et al and Peterson et al on the other hand could not identify such effects in their studies [30, 31, 34] .
Results from California are mixed: Li et al [35] and Romano et al [36] found no evidence of risk selection when they looked at patient case mix, but argue that high-mortality hosptals might have avoided high-risk patients. Moreover, Werner et al [37] found a transient negative effect on access to CABG surgery for African American patients, as they were less likely to receive CABG surgery. In the consecutive year (1996), Mukamel et al [38] found that non-whites are more likely to receive surgery from low-quality surgeons. Overall, although study results are contradictory in details, there was some evidence that PR reduced access to surgery for very sick patients and patients from different ethnic backgrounds.
However, adverse selection is a topic that is difficult to assess, prone to a number of biases, and vulnerable to the availability of high quality data. Maythams et al study [39] suffered from potential responder bias due to low response rate of 50%, and, generally, the surveys conducted represent weaker evidence due to social acceptability bias. Narins et al [40] reported that 88% agreed or strongly agreed that "physicians may report higher risk conditions to improve their outcomes", while 57% of respondants in Brown´s et al study felt that surgeons and hospitals can manipulate the data [41] . Further, studies fail to clearly attribute exposure or provide control groups [42] , suffer from missing data [43] or were conducted based on patient [44] or provider subgroups [45] . Moreover, even if adverse selection took place, this may not necessarily suggest lower quality of care: It has been suggested that the less invasive percutaneous coronary intervention (PCI) might be a substitute treatment for CABG patients being considered too sick to be offered surgery. Dranove et al [32] looked at PCI as a substitute for CABG in NY, where only CABG outcomes were reported. They also found that percutaneous transluminal coronary angioplasty (PTCA) procedure numbers decreased and that hospitals might have taken general measures to avoid high risk patients. Their dataset was, however, restricted to Medicare claims.
Consequently, because of the diverse nature of study designs applied, systems and patient groups studied, the evidence of consequences of public reporting is limited and its impact on quality of care outcomes needs to be interpreted with great caution. Use of data by providers to improve quality of care A key claim of "Offer 2" is that public reports could be used by the public to choose a provider, by GPs to inform referrals and by commissioners to contract for outcomes. This review found limited evidence for such interactions in health systems with a history of surgeon reporting. Two surveys assessed the usage of the data in interactions between surgeons and patients. Burack et al found that 29% discussed the dataless than weekly with their patients and 44% frequently (less than weekly) with colleagues [46] . Moreover, the study suggests that understanding of the methods underlying the published outcomes was limited amongst the surgeons. In the study by Hannan et al [47] , 22% agreed that they routinely discussed the information in the report with their patients. Based on the literature, only a minority of surgeons seem to discuss their outcomes with patients on a regular basis. It has to be taken into account that all these studies were surveys from the USA; there was no data available yet from UK since the introduction of "Offer 2". However, investigations and organizational changes amongst hospitals with suspicious surgeon outcomes could be a relevant implication of public reporting. Dziuban [48] and Chassin [49] interviewed staff from hospitals which were published as having high mortality rates. All hospitals were subjected to special measures and required to undergo a case review. In two cases a lack of dedicated cardiac surgery support staff was identified, the other two identified the approach to the treatment of emergency cases as the cause of the high mortality rate. Strikingly, Dziuban reported an increased team cooperation as one of the salient positive outcomes of the investigation into the high mortality rate. The reports demonstrate that the reasons for high MRs are complex and may not only be attributable to the surgeons themselves.
A proposition put forward by the proponents of public reporting is that learning about their performance compared to peers might lead to increased intrinsic motivation of surgeons to perform better as opposed to extrinsic motivation due to remuneration. We did not find research to support this proposition. Economic models exist to demonstrate the influence of intrinsic motivation on surgeon performance [50] , however, such models rely on a large number of assumptions. A more pertinent implication of surgeon reports might be that low-performing surgeons cease practicing. Jha et al [51] and Hannans et al [47] studies indicate that a larger percentage of bottom quartile surgeons stopped practice in NY than top quartile. Similarly, in Hannans study, the decline in mortality rate was partly attributable to low-volume surgeons with high mortality rate that ceased to practice [47] .
Discussion
The aim of this study was to assess the international evidence on public reporting with a special focus on the two contrasting theses surrounding the introduction of the UK surgeon-level outcomes public reporting initiative: improved quality through better reflection on outcomes by patients, GPs, CCGs or managers and adverse consequences of public reporting on patient selection
We found a substantial literature assessing potential and observed adverse consequences of public reporting and less literature addressing the mechanisms that translate public reporting into quality improvement initiatives, with the largest effects to be expected amongst the lowest performing providers. The findings need to be interpreted with great caution. The variety of methodological approaches (design with/without control group or surveys with risk of bias) make it difficult to reach a final conclusion on the presence and extent of adverse selection of patients according to risk [8] . Questions have also been raised concerning the reliability of underlying data sources, the extent and impact of missing data, the comparability of clinical and administrative sources, and variations in approaches to coding the data. Moreover, the mortality risk of a patient is influenced by the patient (e.g severity of illness or comorbidities) as well as the treatment. Since the beginning of PR, the appropriateness of the risk-adjustment procedures has been questioned and criticized. The NYCS has updated their risk-adjustment several times [52, 53] but research suggests that different methods of risk adjustments will lead to different results [54, 55] .
More fundamentally, however, is the question to what extent the literature (mostly derived from the experience of public reporting of cardiac surgeon outcomes in NY state) supports a generalizability of the findings to the UK context. In the US healthcare system with its many health insurances and where surgeons are not necessarily employed by a hospital [56] , PR might offer a stronger incentive for patient risk selection than in the UK, where surgeons are less dependent on the market. Thus, this evidence might not be applicable to the UK NHS (the only UK study about patient access to care could not found evidence of gaming). In order to assess the transferability of the resuls, the processes through which public reporting should lead to the desired effect will be elucidated in more detail below. Subsequently we will present some factors that policy makers may consider when devising a surgeon outcome initiative in their own country.
Whether public reporting can be an incentive for quality improvement can not be easily answered. From a behavioural economics perspective, PR data can be seen as a `nudge` [57] , that means providing feedback to intrinsically motivated surgeons, who will then act accordingly and try to improve [58] . Kolstad´s study showed a higher impact f intrinsic motivation on NY surgeons' quality improvement than their revenue had [50] .
In fact surgeons were willing to forego parts of their revenue to improve quality. An alternative behavioral economics mechanism for public reporting to drive quality improvement is via cognitive bias that can come into play leading individuals to fear deviating from accepted standards more than appreciating the potential to improve their care [59] . The prospect of being ´named & shamed´ might lead surgeons to change their choice of patients in order to avoid becoming an outlier, as discussed above. According to Kolstad, motivation is highest when expected and observed performance are far apart, whether better or worse than expected, yet the UK PR data as presented online mainly distinguishes between `OK´ performance and ´negative outlier´. As the media focuses on the negative outliers, this is a plausible mechanism for PR functioning. Chassin showed that low performers are more likely to leave the practice, so the PR might indeed have had an effect [49] .
Transparency and consumer choice are also often mentioned as reasons to justify PR efforts [6] . Some doctors go as far as claiming that consent to a procedure can only be given, and be valid, if the patient is aware of the surgeon's performance [60] . Survey results from the USA suggest that mortality data is not often discussed between doctors and patients. This finding is in line with other research that shows that patients found it difficult to understand outcome measures and value more highly recommendations from family and friends [10] . In the UK, where patients traditionally have less choice, data usage might be even less significant and, should this be the case, PR a weaker incentive.
An assessment of whether public disclosure of surgeon outcomes can be translated to other settings also needs to consider the health care delivery system in which the surgeon operates. In this sense, public reporting can be considered as a complex improvement intervention of which the active ingredient is not well understood. For example, case studies of US hospitals that faced high MR show evidence that the published outcomes are rarely attributable to the surgeon alone. Organisational structures and a lack of dedicated staff and procedures can also have a large impact on patient outcomes [61] . Similarly, the three surgeons (out of more than 5000) who were found to be negative outliers in the UK so far faced an individual review as well as a review of their whole unit [62] . Organizational measures were taken rather than retraining of the surgeon [63] [64] [65] . On the other hand, a clear accountability can also be considered as a requirement to improve team efforts [66] .
The absence of controlled studies means that is difficul to separate the effect of public reporting from other strategies. There is also evidence that non-PR feedback can improve quality as well: in New England outcomes feedback, hospital visits and training in quality improvement were combined. The mortality rate went down as various measures were taken at the hospital level-multiprofessional reviews on clinical processes, protocol implementation, reviews of deaths, hiring dedicated cardiac surgery staff, training and implementation of checklists [67] . This then also raises the question of whether an individual surgeon represents the right unit of analysis. In the USA, where surgeons might not be employed by the hospital, and in cardiac surgery where procedure volume is high, the answer might be different from in the UK, and for a different procedure (say, upper gastro-intestinal surgery, with its much lower caseload per surgeon). Whether the statistical power is sufficient to detect variations in quality outcomes is an issue we have raised previously, and a prerequisite for public reports to unfold their effects [68] . This depends mostly on the expected outcome, the volume of cases per surgeon and the number of surgeons performing the operation. These seemingly technical details are a good example to illustrate the limitations of transferring research evidence from one setting to another.
Ideally, in order to appraise research evidence to support translating a health system strategy from one setting to another one should a-priori consider the key factors that determine the translation. At the conceptual level (as reflected in the "generic quality criteria for cross-country comparisons of health systems and policies"), this implies appropriate use of theory, explicit selection of country comparator, rigour in the comparison design, attention to the complexity of the cross-national comparison, rigour of the research method and a clear contribution of knowledge for both theory development and policy learning [69] . In the contect of public reporting of surgeon outcomes, we have outlined in this review a wide range of the factors underlying the effectiveness of public reporting, a diverse set of theories to postulate the expected results and to formulate the implicit causal pathways, all of which will determine to what extent the published evidence is appropriate to justify the proposed health system strategy, in this case the formulation of "Offer 2".
Based on the published literature and our analysis presented here, we suggest specific criteria for cross-country learning from public reporting initiatives, which may support other countries to assess the potential impact of public reporting of surgeon outcomes and to devising a public reporting strategy. These criteria cover health system factors, surgeon factors, data related factors, patient factors, and organizational factors -Existing public reporting system: has some data (say hospital level outcomes) already been puiblished?
-What is the role of the GP in the referral system (gatekeeping, direct referral) and are there other means of patient referral or relevance in the context of public reporting?
-Purchasing mechanisms: how are services contracted for -based on volume or based on outcomes -Number of surgeons conducting the procedure: how many surgeons care conducting the operation in the health system -How will the results be published: is there a single entry portal?
-Does the single entry portal contain patient education material beyond the outcome data?
Surgeon factors:
-Employed or independent: are surgeons on a fixed-appointment with a hospital or clinic, or do they freely operate in different organizations -Competition: do surgeons compete for patients?
-Type and volume of procedures covered: which procedure should be publicly reported? Depending on the case volume and accountability there will be major implications for the public reporting initiative
Data related factors:
-Is quality data available (clinical registry or high quality administrative data)?
-Have appropriate risk adjustment mechanisms for the procedure been developed?
-What is the median delay from procedure to registration to analysis to public report?
Patient factors:
-Does the entire population have easy access to the Internet?
-How is the health literacy level amongst the target population?
-Are there major regional variations in access surgery (limiting patient choice)?
Organizational and professional:
-Do hospitals/clinics have the capacity for team and hospital level discussions to learn from outlying performers?
-Is there a national agency in charge of liaising with low performers to ensure that appropriate investigations, where appropriate, are initiated?
Limitations
This review has several limitations. Due to the diverse range of studies and outcomes included, a meta-analysis of the could not be conducted.
Some studies were not included due to lack of access, or due to not being published in a peer-reviewed journal. The studies included showed varying quality. No study addressed the the question of this review entirely, so that different pieces of information had to be put together and evaluated in relation to each other. Public reporting in the literature so far has mostly addressed mortality outcomes. The public reporting mechanisms will be the same for other outcomes, yet the effectiveness of mechanisms might differ. For example, patient reported outcomes might offer better metric properties (in the context of surgeons outocomes, where denominators are small) and might also lead for a more active engagement of patients [68] . Finally, most studies (n=22) found were from the USA with limited applicability to a UK context, therefore, we have emphasized the transferability of the results to different health system contexts..
Conclusions
PR represents a well established but not yet fully understood approach to improving quality of healthcare. As most research on PR is from a US context, the findings can't easily be transferred to the potential use by GPs and clinical commissioning groups in the NHS (or health care providers and purchasing agencies in different health systems). Therefore, if public reporting is introduced at population level, access to surgery and potential negative effects (adverse selection) should be monitored. Policy makers devising a strategy to publish surgeon outcomes in their own health systems may benefit from contemplating the factors presented here that address the transferability of the evidence underlying the public reporting of surgeon outcomes and specifically, whether prevailing health system conditions are supportive of such a strategy. 
